Filters
Other countries
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
OnkoRisk Hereditary Oncology Plus Panel BioReference Health United States | 97 | 77 |
|
OnkoRisk Hereditary Oncology Management Panel BioReference Health United States | 47 | 17 |
|
Gastric cancer panel (17 genes) Molecular Genetics Laboratory North York General Hospital Canada | 3 | 17 |
|
Hereditary breast, ovarian, prostate, GI cancer panel (36 genes) Molecular Genetics Laboratory North York General Hospital Canada | 18 | 36 |
|
Hereditary GI cancer panel (31 genes) Molecular Genetics Laboratory North York General Hospital Canada | 13 | 31 |
|
Invitae Expanded Renal Disease Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 693 | 388 |
|
Invitae Adenomatous Polyposis Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 7 | 2 |
|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
Centogene AG - the Rare Disease Company Germany | 218 | 135 |
|
Centogene AG - the Rare Disease Company Germany | 74 | 34 |
|
Centogene AG - the Rare Disease Company Germany | 5 | 1 |
|
APC - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 5 | 1 |
|
CASP10 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 3 | 1 |
|
FGFR2 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 11 | 1 |
|
IL1RN - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 3 | 1 |
|
PIK3CA - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 14 | 1 |
|
MUTYH - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Invitae Multi-Cancer + RNA Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 142 | 63 |
|
Invitae Common Hereditary Cancers + RNA Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 114 | 47 |
|
Genome-Nilou Lab Iran | 45 | 34 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.